Field & Main Bank cut its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 22.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,667 shares of the conglomerate’s stock after selling 775 shares during the quarter. Field & Main Bank’s holdings in Danaher were worth $612,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. Coronation Fund Managers Ltd. boosted its position in Danaher by 29.9% during the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after purchasing an additional 1,470 shares in the last quarter. Ascent Group LLC increased its holdings in shares of Danaher by 30.2% during the 2nd quarter. Ascent Group LLC now owns 2,205 shares of the conglomerate’s stock worth $551,000 after buying an additional 512 shares during the last quarter. Quarry LP grew its position in Danaher by 250.6% in the second quarter. Quarry LP now owns 298 shares of the conglomerate’s stock worth $74,000 after acquiring an additional 213 shares during the period. Regal Investment Advisors LLC grew its holdings in shares of Danaher by 1.9% during the 2nd quarter. Regal Investment Advisors LLC now owns 8,581 shares of the conglomerate’s stock worth $2,144,000 after purchasing an additional 157 shares during the period. Finally, B. Riley Wealth Advisors Inc. raised its stake in shares of Danaher by 5.0% in the second quarter. B. Riley Wealth Advisors Inc. now owns 11,035 shares of the conglomerate’s stock valued at $2,760,000 after acquiring an additional 527 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Analyst Upgrades and Downgrades
DHR has been the subject of a number of recent analyst reports. Citigroup decreased their price target on Danaher from $305.00 to $285.00 and set a “buy” rating for the company in a report on Monday, January 6th. KeyCorp boosted their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Scotiabank assumed coverage on shares of Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price for the company. Guggenheim started coverage on shares of Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price objective for the company. Finally, Evercore ISI increased their price target on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Six equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $285.81.
Danaher Stock Performance
DHR stock opened at $230.22 on Wednesday. Danaher Co. has a 12 month low of $225.42 and a 12 month high of $281.70. The company has a market capitalization of $166.28 billion, a price-to-earnings ratio of 43.90, a P/E/G ratio of 4.43 and a beta of 0.83. The firm has a 50 day moving average of $236.09 and a two-hundred day moving average of $253.66. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. During the same quarter in the prior year, the company earned $2.09 EPS. As a group, equities analysts anticipate that Danaher Co. will post 7.5 EPS for the current fiscal year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio is presently 20.61%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Most Volatile Stocks, What Investors Need to Know
- 3 Steel Stocks Soaring After Tariff Announcements
- What is Forex and How Does it Work?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- How to Invest in Small Cap StocksÂ
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.